YWP
IPXL

YorkBridge Wealth Partners’s Impax Laboratories, Inc. IPXL Stock Holding History

YorkBridge Wealth Partners’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-112
Closed -$2K – 905
2018
Q1 		$2K Sell
112
-25
-18% -$491 ﹤0.01% 811
2017
Q4 		$3K Buy
137
+50
+57% +$916 ﹤0.01% 780
2017
Q3 		$2K Sell
87
-19
-18% -$363 ﹤0.01% 826
2017
Q2 		$2K Buy
106
+35
+49% +$517 ﹤0.01% 818
2017
Q1 		$1K Buy
+71
New +$858 ﹤0.01% 862

YorkBridge Wealth Partners's IPXL Position: Q2 2018 in Review

YorkBridge Wealth Partners sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 112 shares — an estimated $2K sold.

YorkBridge Wealth Partners first reported a position in IPXL in Q1 2017 and held it in 5 quarters. The position peaked at $3K in Q4 2017. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

  • YorkBridge Wealth Partners reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
  • YorkBridge Wealth Partners sold 112 Impax Laboratories, Inc. shares in Q2 2018, an estimated $2K.
  • YorkBridge Wealth Partners first reported a position in Impax Laboratories, Inc. in Q1 2017 and held it in 5 quarters.
  • YorkBridge Wealth Partners's Impax Laboratories, Inc. position peaked at $3K in Q4 2017.
  • 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on YorkBridge Wealth Partners's 13F filing for Q2 2018, filed 10 Aug 2018.